References

Gal TJ, Shinn J, Huang B. Current epidemiology and management trends in acoustic neuroma. Otolaryngol Head Neck Surg. 2010; 142:677-681 https://doi.org/10.1016/j.otohns.2010.01.037
Gupta VK, Thakker A, Gupta KK. Vestibular schwannoma: what we know and where we are heading. Head Neck Pathol. 2020; 14:1058-1066 https://doi.org/10.1007/s12105-020-01155-x
Demetriades AK, Saunders N, Rose P Malignant transformation of acoustic neuroma/vestibular schwannoma 10 years after gamma knife stereotactic radiosurgery. Skull Base. 2010; 20:381-387 https://doi.org/10.1055/s-0030-1253576
Evans DG, Moran A, King A Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol Neurotol. 2005; 26:93-97 https://doi.org/10.1097/00129492-200501000-00016
Asthagiri AR, Parry DM, Butman JA Neurofibromatosis type 2. Lancet. 2009; 373:1974-1986 https://doi.org/10.1016/S0140-6736(09)60259-2
Berkowitz O, Iyer AK, Kano H Epidemiology and environmental risk factors associated with vestibular schwannoma. World Neurosurg. 2015; 84:1674-1680 https://doi.org/10.1016/j.wneu.2015.07.007
Han YY, Berkowitz O, Talbott E Are frequent dental x-ray examinations associated with increased risk of vestibular schwannoma?. J Neurosurg. 2012; 117 Suppl:78-83 https://doi.org/10.3171/2012.5.GKS12615
Morgan LL, Miller AB, Sasco A, Davis DL. Mobile phone radiation causes brain tumors and should be classified as a probable human carcinogen (2A) (review). Int J Oncol. 2015; 46:1865-1871 https://doi.org/10.3892/ijo.2015.2908
Schneider AB, Ron E, Lubin J Acoustic neuromas following childhood radiation treatment for benign conditions of the head and neck. Neuro Oncol. 2008; 10:73-78 https://doi.org/10.1215/15228517-2007-047
Foley RW, Shirazi S, Maweni RM Signs and symptoms of acoustic neuroma at initial presentation: an exploratory analysis. Cureus. 2017; 9 https://doi.org/10.7759/cureus.1846
Holt DJ, Foy PM, Field EA. Orofacial paraesthesia: an unusual presentation of acoustic neuroma. Dent Update. 2002; 29:141-142 https://doi.org/10.12968/denu.2002.29.3.141
Lam R. Acoustic neuroma manifesting as toothache and numbness. Aust Dent J. 2016; 61:109-112 https://doi.org/10.1111/adj.12302
Moazzam AA, Habibian M. Patients appearing to dental professionals with orofacial pain arising from intracranial tumors: a literature review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012; 114:749-755 https://doi.org/10.1016/j.oooo.2012.06.017
Lin EP, Crane BT. The management and imaging of vestibular schwannomas. AJNR Am J Neuroradiol. 2017; 38:2034-2043 https://doi.org/10.3174/ajnr.A5213
Silk PS, Lane JI, Driscoll CL. Surgical approaches to vestibular schwannomas: what the radiologist needs to know. Radiographics. 2009; 29:1955-1970 https://doi.org/10.1148/rg.297095713
Lu VM, Ravindran K, Graffeo CS Efficacy and safety of bevacizumab for vestibular schwannoma in neurofibromatosis type 2: a systematic review and meta-analysis of treatment outcomes. J Neurooncol. 2019; 144:239-248 https://doi.org/10.1007/s11060-019-03234-8
Schick B, Dlugaiczyk J. Surgery of the ear and the lateral skull base: pitfalls and complications. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2013; 12 https://doi.org/10.3205/cto000097
Kemink JL, Langman AW, Niparko JK, Graham MD. Operative management of acoustic neuromas: the priority of neurologic function over complete resection. Otolaryngol Head Neck Surg. 1991; 104:96-99 https://doi.org/10.1177/019459989110400117
Doherty JK, Friedman RA. Controversies in building a management algorithm for vestibular schwannomas. Curr Opin Otolaryngol Head Neck Surg. 2006; 14:305-313 https://doi.org/10.1097/01.moo.0000244186.72645.d4
Schmerber S, Palombi O, Boubagra K Long-term control of vestibular schwannoma after a translabyrinthine complete removal. Neurosurgery. 2005; 57:693-698

Three numb tongues, two MRIs and a gold weight in an eyelid: a case series of acoustic neuromas and their relevance to dental practice

From Volume 50, Issue 1, January 2023 | Pages 41-47

Authors

Robert JR Reilly

Clinical Lecturer and Honorary Registrar in Oral Medicine, University of Glasgow, MVLS, School of Medicine, Dentistry and Nursing. Department of Oral Medicine, Glasgow Dental Hospital and School, NHS Greater Glasgow and Clyde

Articles by Robert JR Reilly

Email Robert JR Reilly

Elizabeth Todd

Department of Oral Medicine, Glasgow Dental Hospital and School, NHS Greater Glasgow and Clyde

Articles by Elizabeth Todd

Kirstyn Donaldson

BDS, MFDS(RCPS Glas) DDMFR(RCR), Consulant in Oral and Maxillofacial Radiology, Glasgow Dental Hospital and School, 378 Sauchiehall Street, Glasgow, G2 3JZ, UK

Articles by Kirstyn Donaldson

Alex Crighton

Consultant, Department of Oral Medicine, Glasgow Dental Hospital and School, NHS Greater Glasgow and Clyde

Articles by Alex Crighton

Abstract

Acoustic neuromas are brain tumours originating from the Schwann cells of the vestibulocochlear nerve. As acoustic neuromas grow, the vestibulocochlear, facial and trigeminal nerves are often compressed, resulting in the common presenting complaints of hearing loss, balance disturbance, facial nerve weakness and altered sensation of the orofacial region. Thus, patients with an acoustic neuroma may present to the dentist with a range of problems. Herein we present three cases of acoustic neuroma that were diagnosed following presentation to the Glasgow Dental Hospital Oral Medicine Department and discuss the common clinical features, radiological findings and management options for acoustic neuromas.

CPD/Clinical Relevance: Dentists should be aware of the common presenting features of acoustic neuromas and when onward referral is indicated.

Article

Acoustic neuromas (AN), also known as vestibular schwannomas or cerebellopontine angle (CPA) tumours are benign tumours originating from the Schwann cells of the vestibulocochlear nerve (CN VIII) (Figure 1).1,2 Although usually benign, it must be noted that there are reports documenting de novo malignancy and malignant transformation.3 A 2010 study of 1621 patients showed an AN incidence rate of 1.1:100,000 with the average age of presentation 53 years, and no reported differences in laterality or affected sex.1 AN account for 8% of all intracranial tumours,4 with the majority of cases being unilateral, less than 5% present bilaterally.1 Bilateral AN is characteristic of neurofibromatosis type 2 (NF2), a genetic condition predisposing the patient to neural, cutaneous and ocular lesions,5 with 7% of AN cases presenting on a background of NF2.4 Other risk factors for AN development are poorly understood, but potentially include high-dose ionizing radiation, atopic disease, mobile phone use, and dental radiographs, although interestingly, tobacco has demonstrated an inverse relationship.6,7,8,9

Register now to continue reading

Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Up to 2 free articles per month
  • New content available